FDA Reverses Authorization of Monoclonal Antibodies to Treat COVID-19 - Contagion Live

Retrieved on: 2022-01-25 18:12:50

Tags for this article:

Medical specialties

Medicine

COVID-19 drug development

Monoclonal antibodies

Clinical medicine

Bamlanivimab

Casirivimab/imdevimab

SARS-CoV-2 Omicron variant

COVID-19

Antibody therapy

Treatment and management of COVID-19

Coronavirus spike protein

Click the tags to see associated articles and topics

FDA Reverses Authorization of Monoclonal Antibodies to Treat COVID-19 - Contagion Live. View article details on HISWAI: https://www.contagionlive.com/view/fda-reverses-authorization-of-monoclonal-antibodies-to-treat-covid-19

Excerpt

The FDA cited monoclonal antibodies as being less effective against the Omicron variant in their decision to rescind their earlier approval of the ...

Article found on: www.contagionlive.com

View Original Article